Pfizer Grant: Emerging Data & Unmet Needs in High-Risk NMIBC

Pfizer Grant: Emerging Data & Unmet Needs in High-Risk NMIBC

Deadline: 14th October 2025
Funding Available: $50,000 – $250,000 per project
Total Budget: $250,000
Project Duration: Up to 12 months
Expected Launch: January 2026

Overview

Pfizer invites proposals for independent medical education projects aimed at addressing critical gaps in the management of high-risk non-muscle invasive bladder cancer (NMIBC). The grant focuses on education and practice improvement, not clinical research or efficacy studies.

Key goals include:

• Raising awareness of emerging data in high-risk NMIBC

• Improving patient management, clinical risk stratification, and patient selection

• Promoting safe and effective integration of PD-(L)1 inhibitor therapies

• Encouraging collaborative decision-making between urology and medical oncology

Scope & Focus Areas

• Understanding disease recurrence and treatment complications

• Exploring innovative approaches to patient management

• Integrating new therapies into clinical practice

• Educational projects with measurable impact on clinician behavior and patient outcomes

Eligible Applicants

• Medical, nursing, pharmacy, and allied health schools

• Healthcare institutions of all sizes

• Professional organizations and medical societies

• Medical education companies with a healthcare improvement mission

Note: Independent medical practices are not eligible. Multi-institution collaborations are allowed, but the lead organization must serve as the primary grant recipient. Continuing education projects must have appropriate accreditation.

Geographic Focus

• Primarily Europe, though globally relevant proposals are also considered

Funding & Use

• Projects may receive $50,000 to $250,000

• Support initiatives that educate clinicians, improve awareness, and enhance clinical practice for high-risk NMIBC

This opportunity is ideal for medical education providers, professional societies, and healthcare institutions aiming to bridge knowledge gaps and improve patient outcomes in NMIBC.

for more information-